Cross-referencing clinical data
A pairing appears on this page only when a trial gave both ingredients together and measured the result. Pediococcus pentosaceus has none that clears that bar.
Stitching two separate single-ingredient studies into a pairing is the one thing this engine will not do. When a study of the combination itself holds up at source, it lands here with its citation.
No invented synergy. Where actives were studied on their own rather than together, the record shows each on its own evidence, never a combined effect no trial measured.
Research strength. Research strength says how much work stands behind the combination. It is never a product score.
Independent record. Every finding is cited to a named trial, dated, and never written by the brand.
20 pairings are live across the library today. Checked 20 July 2026.
No study gave these as a pair, so they are not in the card above. But the reason they belong together is settled biochemistry, not a guess, so it is worth knowing.
A published trial used Bifidobacterium longum KABP042 together with Pediococcus pentosaceus KABP041 as a single mixture and compared it against a Lactobacillus reuteri comparator in infants. The result belongs to the mixture, so neither strain's contribution can be separated out from it. Strain identity matters here more than genus. A different B. longum strain is not the one that was studied.
P. pentosaceus and L. plantarum are the classic pair in sauerkraut, silage and fermented sausage, with the Pediococcus tolerating higher salt and lower temperature. In a formula they cover complementary conditions. That is fermentation technology, well established. Whether the pair does anything in the human gut that either does alone has not been tested.
Inulin is a fermentable substrate for many lactic acid bacteria, giving a synbiotic pairing on paper. P. pentosaceus is a strong pentose and hexose fermenter, which is where its name comes from. Whether inulin specifically favours this organism over the resident population in a human gut has not been shown. Read the pairing as a formulation rationale.
FOS is fermented rapidly in the proximal colon to lactate and acetate, which lowers local pH. That environment favours lactic acid bacteria over acid-sensitive organisms. The reasoning is sound and generic to the group. It is not specific evidence for this species.
GOS survives digestion and reaches the colon intact where lactic acid bacteria ferment it. Products pairing this species with GOS use that logic. As with FOS, the substrate is not selective for this organism. State it as substrate availability, not targeted feeding.
Resistant starch reaches the colon undigested and is fermented mainly to butyrate by other organisms, with lactate-producing bacteria feeding the cross-feeding chain. P. pentosaceus contributes lactate that butyrate producers can use. The cross-feeding relationship is established in the group. Its size with this particular species is not.
S. boulardii is a yeast and is unaffected by conditions that limit bacterial strains, which is why the two are stacked. There is no shared metabolic dependency here, just non-overlapping coverage. No trial has tested this specific pair. Regard it as formulation reasoning.
Riboflavin-overproducing lactic acid bacteria are used to raise B2 content in fermented foods. Whether a given P. pentosaceus strain does this depends entirely on the strain, and most do not. Do not carry this across from genus to product. It belongs in the fermentation column, not the supplement column.
Nothing specific on file for Pediococcus pentosaceus. Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.These are the studies our verdict leans on, chosen from the 7 we read for Pediococcus pentosaceus. The full linked list is below.
2 sources behind our Pediococcus pentosaceus verdict: peer-reviewed studies and registered clinical trials. Every one links straight to PubMed, the journal, or ClinicalTrials.gov. Read them yourself.
Evidence surfaced via Semantic Scholar (Allen Institute for AI) and ClinicalTrials.gov. Ranked by study type and citation weight, not cherry-picked.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.